Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.87p
   
  • Change Today:
      0.008p
  • 52 Week High: 4.05
  • 52 Week Low: 0.87
  • Currency: UK Pounds
  • Shares Issued: 274.89m
  • Volume: 0
  • Market Cap: £2.38m
  • RiskGrade: 304

Regulatory News

Price Monitoring Extension 12-Oct-2022 16:35 RNS
Clinical trial update 12-Oct-2022 07:00 RNS
Second Price Monitoring Extn 10-Oct-2022 11:05 RNS
Price Monitoring Extension 10-Oct-2022 11:00 RNS
SFX-01 licensing deal for up to $160.5m 10-Oct-2022 07:00 RNS
Regulatory approval for healthy volunteer study 29-Sep-2022 07:00 RNS
Result of AGM 22-Jul-2022 07:00 RNS
Investor Presentation 14-Jul-2022 12:43 RNS
Notice of AGM 06-Jul-2022 12:25 RNS
Collaboration with University of Michigan 13-Jun-2022 07:00 RNS
Full Year Results 08-Jun-2022 07:00 RNS
Notice of Results 07-Jun-2022 07:00 RNS
Collaboration with Università Sapienza di R... 25-May-2022 07:00 RNS
Holding(s) in Company 29-Apr-2022 14:39 RNS
Second Price Monitoring Extn 15-Mar-2022 14:05 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 0.87p
Change Today 0.008p
% Change -0.95 %
52 Week High 4.05
52 Week Low 0.87
Volume 0
Shares Issued 274.89m
Market Cap £2.38m
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.01% above the market average35.01% above the market average35.01% above the market average35.01% above the market average35.01% above the market average
85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average
Price Trend
89.94% below the market average89.94% below the market average89.94% below the market average89.94% below the market average89.94% below the market average
75.44% below the sector average75.44% below the sector average75.44% below the sector average75.44% below the sector average75.44% below the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Evgen Pharma Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page